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Abstract
Background: Previous small studies suggested SBOT may be ineffective in relieving breathlessness after exercise in
COPD.
Methods: 34 COPD patients with FEV1 <40% predicted and resting oxygen saturation ≥93% undertook an exercise
step test 4 times. After exercise, patients were given 4 l/min of oxygen from a simple face mask, 4 l/min air from a
face mask (single blind), air from a fan or no intervention.
Results: Average oxygen saturation fell from 95.0% to 91.3% after exercise. The mean time to subjective recovery
was 3.3 minutes with no difference between treatments. The mean Borg breathlessness score was 1.5/10 at rest,
rising to 5.1/10 at the end of exercise (No breathlessness = 0, worst possible breathlessness = 10). Oxygen therapy
had no discernable effect on Borg scores even for 14 patients who desaturated below 90%. 15 patients had no
preferred treatment, 7 preferred oxygen, 6 preferred the fan, 3 preferred air via a mask and 3 preferred room air.
Conclusions: This study provides no support for the idea that COPD patients who are not hypoxaemic at rest
derive noticeable benefit from oxygen therapy after exercise. Use of air from a mask or from a fan had no
apparent physiological or placebo effect.
Background
Oxygen therapy is beneficial for many patients with
chronic obstructive pulmonary disease (COPD). It is
used to correct dangerous hypoxaemia in acute exacer-
bations of COPD and it is known that long term oxygen
therapy (LTOT) can prolong life expectancy in patients
with COPD who have got chronic hypoxaemia, espe-
cially if there is evidence of cor pulmonale [1-3]. It has
also been demonstrated that the use of ambulatory oxy-
gen therapy during exercise tests in the laboratory can
increase exercise distance and reduce exercise-induced
breathlessness in patients with COPD who desaturated
during exertion although the reported benefits in the
home environment were less impressive [4-7]. The most
controversial form of oxygen therapy in COPD is
known as short burst oxygen therapy (SBOT) [8]. This
involves the use of oxygen either before or, more
commonly, after exercise by patients with COPD who
are not hypoxaemic at rest. This form of treatment
appears to be especially common in the UK where it is
estimated that about £18 million (approximately $25
million) per annum is spent on oxygen cylinders that
are used in patients’ homes [9] although there is very lit-
tle evidence to support this practice. Previous short-
term studies of SBOT for patients with COPD involved
small numbers of patients and most of the trials failed
to demonstrate any benefit from the use of SBOT either
before or after exercise [10-19]. In one long-term study
[20], patients who were randomized to “SBOT” using
either oxygen or a placebo cylinder (air) over a six
month period had high initial use of both types of cylin-
der and very low use subsequently and there was no dif-
ference between the use of oxygen or air cylinders. Two
systematic reviews have concluded that the published
studies do not support the use of SBOT for patients
with COPD [8,21]. It has been suggested that some of
the apparent benefits from oxygen therapy may be due * Correspondence: ronan.o.driscoll@srft.nhs.uk
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on the face or nose [22,23].
We conducted a partially single-blind study of oxygen
compared with air from a face mask in patients with
severe COPD who were not hypoxaemic at rest. Our
aim was to determine if patients given oxygen would
recover more quickly from exercise-induced breathless-
ness compared with patients given air. We also evalu-
ated the possibility that patients might derive
symptomatic benefit from having a flow of air delivered
to the face by an electric fan.
Methods
This trial was designed as a partially single-blind cross-
over assessment of the short-term response to SBOT
amongst a group of patients attending the outpatient
service in a University Hospital with severe COPD and
limitation of activities of daily living due to breathless-
ness. The co-primary objectives were to determine
whether SBOT given after exercise to non-hypoxaemic
patients with COPD can (a) reduce dyspnoea during
recovery from exercise or (b) shorten the recovery per-
iod. Oxygen therapy was compared with room air, com-
pressed air from a face-mask or air blown on the face
by an electric fan.
The secondary objectives were to determine; 1.
Whether there is any difference in dyspnoea and time to
recovery if a patient breathes room air, room air blown
by an electric fan or compressed air via face mask; 2.
Whether there is any difference in the subjective
response to oxygen between patients who desaturate on
exercise (SpO2 below 90% on at least two occasions
during or after exertion in this study) and those who do
not 3. Whether the subjective benefit from oxygen
noted in some previous studies was due to a cooling air-
flow on the face or a physiological benefit from Oxygen.
Patients were recruited from the chest clinic or pul-
monary rehabilitation service at Salford Royal University
Hospital. We recruited only patients who experienced
significant breathlessness on minor exertion and who
wished to be considered for symptomatic treatment with
oxygen (SBOT) at home. Eligible patients were invited
to take part in the study and given an information leaf-
let describing the study, with opportunities to ask ques-
tions of a doctor or respiratory nurse specialist prior to
inclusion in the trial. Written informed consent was
obtained before each patient could enter the study and
the trial protocol was approved by the Salford and Traf-
ford Local Research Ethics Committee, reference 04/
Q1404/21.
Inclusion Criteria
Patients aged over 50 years with smoking history of
more than 20 pack years; Severe COPD with FEV1 less
than 40% predicted value;[24] Oxygen saturation at rest
≥ 93% breathing room air at time of recruitment to
study and on arrival on study day; Breathless during
modest exercise such as climbing one or two flights of
stairs; Stable for 4 weeks (Not requiring oral steroids or
antibiotics or both); Able to give informed consent; Able
to undertake a simple step test on an 18 cm exercise
step.
Exclusion Criteria
Unable or unwilling to give informed consent; Unable or
unwilling to undertake step test for any reason; Compli-
cating co-morbid conditions (e.g. arthritis of knees)
which might interfere with exercise test or with the con-
duct of trial; Patients already using oxygen cylinders at
home.
All exercise tasks were supervised by a single observer
(JN). On the study day, patients completed the following
procedures; The Oxygen saturation (SpO2) and baseline
pulse were measured using a single Minolta Pulsox-3
oximeter. A Borg Dyspnoea score [25] (0 = not breath-
less, 10 = maximal breathlessness) was administered
after at least 10 minutes of rest in a seated position. The
patient then performed the first of four exercise step
tests by stepping on and off a standard 18 cm exercise
step as previously described [26,27]. Patients were
instructed to exercise for up to 3 minutes at the fastest
sustainable pace that was comfortable for them. The
patients were instructed to stop before 3 minutes if they
felt that they had reached comfortable limits (for what-
ever reason). The oxygen saturation and pulse rate were
monitored continuously using the same finger oximeter
for every test. The SpO2 and pulse rate were recorded
in the patient’s trial record sheet each minute during
the exercise test, at the end of exercise and every minute
during recovery until 5 minutes after finishing the exer-
cise task. Patients completed a modified Borg dyspnoea
score before and immediately after the exercise task and
every minute for 5 minutes during the recovery period.
The investigator recorded the objective recovery time
defined as the time when the pulse rate had recovered
to within five beats per minute of the baseline pulse.
The subjective recovery time was measured by asking
patients every minute during the recovery period if their
sense of breathlessness had returned to the level that it
was at before exercise.
Patients rested for at least 30 minutes after full recov-
ery from each exercise task and they undertook a total
of four exercise tasks on the same day. Immediately
after completing each exercise task, patients received
one of the following interventions in random order
based on the patient drawing four pieces of folded paper
sequentially from an opaque container prior to the com-
mencement of the exercise task. Each piece of paper
O’Driscoll et al. BMC Pulmonary Medicine 2011, 11:23
http://www.biomedcentral.com/1471-2466/11/23
Page 2 of 7contained a single letter which determined the order of
treatment as follows: a) Room air (no intervention). b)
Use of an electric fan with 28 cm blades to blow cool
air on the face from a distance of one meter (Type FT-
30 fan from Guangdong Zhongshan Household Electric
Appliance General Factory, China; set at highest speed
setting). c) Air at 4 liters per minute from a simple face
mask (Venticaire medium concentration oxygen mask,
from Flexicare Medical Limited UK). d) Oxygen at 4
liters per minute (approximately 35% oxygen) from the
same mask in a single blind manner. Allocation to treat-
ment order took place after all other aspects of trial
recruitment to avoid any possible recruitment bias. The
oxygen and air treatments were single blind. To achieve
blinding for these two interventions, the investigator
connected a concealed air or oxygen cylinder delivering
a gas flow of 4 liters per minute to the same face mask
for each patient.
Statistics
The study of Nandi et al [18] was used to determine the
number of subjects required for the trial. We estimated
that a crossover study involving 40 patients would have
80% power to detect a significant difference in the objec-
tive recovery time comparing oxygen with air. All data
were entered in a scientific database (Graph Pad Prism4)
and analyzed in that database. Data for each group were
compared using Wilcoxon matched pairs test.
Results
39 patients were recruited and gave written informed
consent to take part in the study. Three patients were
found to have recent FEV1 above 40% predicted and
their results were not analyzed. One patient was hypox-
aemic breathing air when he attended for the study
(SpO2 88%) and one patient withdrew from the study
a f t e ro n eo ft h ef o u re x e r c i s et a s k s .D e t a i l so ft h e3 4
patients who completed the study are shown in Table 1.
Patients climbed an average of 35 steps in an average
of 94 seconds. The mean number of steps climbed (SD)
was as follows. First task 34.9 steps (22.6); second task
35.1 steps (17.2); third task 35.2 steps (16.8); fourth task
35.0 steps (16.3). The patients’ oxygen saturation and
pulse rates were well matched before each exercise task
and at the end of each of the four exercise periods as
shown in table 2.
The mean oxygen saturation fell from 95.0% pre-exer-
cise to 91.3% at the end of the exercise task and the
speed of SpO2 recovery to the baseline level was almost
identical when room air, mask air and the electric fan
were used in the recovery period (Figure 1). Oxygen
saturation rose more quickly and to a higher level when
the oxygen mask was used (p < 0.009 compared with
the other treatments at 1 minute and <0.0001 there-
a f t e r ) .H o w e v e r ,t h i si n c r e a s ei no x y g e ns a t u r a t i o no f
about 2% had no effect on the subjective sense of
breathlessness as measured by the Borg score during the
recovery period (Figure 2). The breathlessness score was
about half a Borg unit higher when the air-mask was
used compared with the other three groups at 1 and 2
minutes after finishing the exercise task (p = 0.01), pos-
sibly reflecting increased resistance due to the mask.
Table 2 shows that the subjective recovery times were
very similar for each of the four interventions with no
significant difference between any of them. However,
the pulse recovery time was almost a minute shorter
when oxygen was given (Figure 3). This achieved statis-
tical significance compared with room air (p < 0.01) and
compared with air from a mask (p = 0.03) but not com-
pared with air from a fan (p = 0.16).
The same pattern of oxygenation, Borg scores and
recovery times was seen amongst the 14 patients who
desaturated below 90% as was seen for the entire cohort
with no significant difference in the Borg score at any time
point or in the subjective recovery time compared with
air. (Table 2 and right hand panels of Figures 1 and 2).
After completing the four exercise tasks, each patient
was asked about their preferred treatment. Fifteen
patients had no overall preference. Of the 19 patients
who expressed a preference, 7 chose the oxygen mask, 6
chose the electric fan, 3 chose air from a mask and 3
preferred room air. The seven patients who expressed a
preference for oxygen amounted to only 21% of the
overall group. Five of these seven patients (71%) had
desaturated during exercise compared with nine of 27
(33%) patients who did not have a preference for oxygen
therapy but this difference did not reach statistical sig-
nificance (Fisher’s exact test p = 0.097).
Discussion
Despite a rapid rise in oxygen saturation, COPD patients
in this study reported no reduction in post-exertion
Table 1 Details of 34 patients who completed the trial
Mean Standard Deviation Range
Age (years) 67.5 8.9 52-87
FEV1 (liters) 0.80 0.2 0.45-1.3
FEV1 as %predicted 31.4% 5.5 21-39
Number of steps climbed 35.0 18.2 7-115
Exercise time (seconds) 93.9 43.1 23-180
SpO2at rest 95.0 1.3 92-98
SpO2 at end of exercise 91.3 3.8 79-97
Pulse at rest 86.1 12.4 51-117
Pulse at end of exercise 103 17.8 57-145
Borg score at rest 1.5 1.1 0-4
Borg score at end of exercise 5.1 1.6 2-9
(24 male, 10 female; 4 current smokers, 30 ex-smokers).
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time when oxygen was given by simple face mask at 4 l/
min compared with air from the same face mask or
compared with a fan blowing air on the face or no inter-
vention. This was true for the full group of 34 patients
and for the sub-group of 14 patients who desaturated
below 90% during exercise. The Borg score was about
half a unit higher (worse breathlessness) when the air
mask was used. Although this slight increase in breath-
lessness may have been caused by increased resistance
to breathing due to the tight-fitting mask, the difference
was probably too small to be clinically relevant. The
pulse recovery time was shorter when oxygen was given
but this did not seem to provide any symptomatic
benefit. Quantrill [12] reported a small improvement of
about 35 seconds in the subjective and objective recov-
ery times when oxygen was given after exercise to
patients with COPD who were already using SBOT at
home and who reported benefit from it’s use. However,
these differences did not reach statistical significance
and only 5 of 22 patients could correctly identify oxygen
from air in Quantrill’s single-blind study.
The present study was larger than all previously pub-
lished studies of the effect of short burst oxygen therapy
for the relief of breathlessness after exertion for COPD
patients. The overall negative results are in line with the
majority of previous studies [10-19] and with two sys-
tematic reviews of short burst oxygen therapy [8,21].
Table 2 Summary of responses to exercise and treatments
Room Air Electric Fan Air Mask Oxygen Mask
Mean exercise time (seconds) 93.7 (42.1) 92.9 (43.2) 94.1 (40.5) 93.0 (46.1)
Mean number of steps climbed 34.1 (17.0) 36.0 (17.1) 36.6 (21.9) 33.4 (16.8)
Mean pulse pre-exercise 86.0 (12.1) 87.3 (13.1) 84.7 (12.0) 86.2 (12.6)
Mean pulse at end of exercise 99.3 (18.6) 103.6 (16.6) 107.0 (19.7) 102.1 (16.2)
Mean SpO2 pre-exercise 95.2 (1.4) 94.8 (1.3) 95.1 (1.3) 94.9 (1.3)
Mean SpO2 at end of exercise 91.3 (4.0) 91.1 (3.7) 91.3 (4.3) 91.5 (3.5)
Mean Borg score pre-exercise 1.5 (1.1) 1.5 (1.2) 1.5 (1.1) 1.6 (1.2)
Mean Borg score at end of exercise 5.1 (1.7) 5.1 (1.7) 5.3 (1.6) 5.1 (1.7)
Mean subjective recovery time (mins) 3.2 (1.1) 3.6 (1.8) 3.3 (1.1) 3.1 (1.2)
Mean objective recovery time (mins) 2.8 (2.0) 2.3 (1.1) 2.9 (2.5) 1.9 (1.0)
Recovery time for sub-group of 14 patients who desaturated
Mean subjective recovery time (mins) 3.2 (1.1) 3.4 (1.1) 3.5 (0.9) 2.9 (1.2)
Mean objective recovery time (mins) 3.0 (1.8) 2.1 (0.9) 3.6 (3.6) 1.9 (1.0)
(Mean and SD).
Figure 1 Oxygen saturation before and after exercise. Left hand panel: All 34 patients. Right hand panel: 14 patients who desaturated below
90%
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or nose may reduce breathlessness by reflex actions
[22,23]. However, we found that none of three interven-
tions which involved gas flow over the face in the pre-
sent study (air mask, oxygen mask or electric fan) had
any significant effect on the patients’ sensation of
breathlessness after exertion. This suggests that any sub-
stantial physiological effect (or placebo effect) from air-
flow from masks or fans on the face is unlikely.
The Borg breathlessness scores were higher at one and
two minutes post exercise when air was given by face
mask at 4 l/minute (Figure 2). This effect was small but
statistically significant (p < 0.01 compared with fan at
one minute and compared with oxygen at two minutes
and p < 0.04 compared with room air at one minute)
and it was more marked for the 14 patients who desatu-
rated (Figure 2, right hand panel). This might be due to
the high respiratory rate in this group leading to a slight
resistance to inspiration caused by inhaling from a small
volume mask entraining a low flow of air [28].
Although the present study is not large, it is the lar-
gest laboratory study of SBOT yet conducted and the
crossover design on a single day yielded very stable
baseline values which made the comparison between
Figure 2 Borg breathlessness scores before and after exercise. Left hand panel: All 34 patients. Right hand panel: 14 patients who
desaturated below 90%
Figure 3 Pulse rates before and after exercise. Left hand panel: All 34 patients. Right hand panel: 14 patients who desaturated below 90%
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ment target of 40 patients but the standard deviation of
the Borg score post exercise (1.6) was lower than that
the value of 1.8 which was reported in a previous similar
study [19]. The achieved sample size of 34 patients gave
a power of 0.94 to detect a difference of 1 Borg unit
with a probability of type 1 error of 0.05.
T h ee x e r c i s es t e pt e s ti sn o ta sw e l lv a l i d a t e di n
COPD as the 6 minute walk test or the shuttle walk test
[29,30]. However, this test has been validated in pre-
vious studies [26,27] and there was excellent reproduci-
bility with no learning effect from the first to the fourth
exercise task in the present study which would further
validate this test. A further advantage of the step test is
that it is similar to the sort of activity such as stair
climbing for which patients actually use SBOT in clini-
cal practice [12]. Furthermore, the step test can be car-
ried out in one to three minutes within the consulting
room as part of a routine consultation but few clinics
have sufficient staff time or floor-space to permit the
use of 6 minute walks or shuttle walk tests within a rou-
tine consultation.
We observed no order effect in the present study . It
is not known if any other outcome measure would be
superior to the Borg score but the lack of benefit in
Borg scores was reflected in the finding that only seven
of 34 patients preferred oxygen compared with the
other interventions. Five of these seven patients had
desaturated during exercise. Although this was not sta-
tistically significant it raises the possibility that a larger
study of “desaturators” might identify a small group of
patients who could gain benefit from short burst oxygen
therapy.
The present trial is in agreement with the majority of
previous studies [10-19] in finding no overall improve-
ment in the mean Borg breathlessness score when oxy-
gen was given after exercise, even for the 14 patients
who had experienced desaturation during the exercise
task and despite a rapid rise in SpO2 on oxygen therapy
and a quickening of the pulse recovery time. As none of
the previous studies have reported large improvements
in breathlessness in response to SBOT, the addition of
the present study to the previous studies strengthens the
current consensus view [1,8,21] that there is no clinically
important benefit for most users of SBOT. By contrast,
there is strong evidence of benefit from pulmonary
rehabilitation for patients with COPD [31] and we
would recommend this as the preferred option for
patients who remain breathless on exertion despite max-
imal medical treatment for COPD.
Although it remains possible that a minority of patients
might benefit from short burst oxygen therapy, ambula-
tory oxygen therapy (to prevent desaturation during exer-
cise) might be more effective for such patients but it is
n o tw i d e l yu s e da tp r e s e n tf o rp a t i e n t sw h oa r en o t
hypoxaemic at rest. The GOLD (Global initiative for
chronic Obstructive Lung Disease) Guideline [32] does
not make any recommendation for or against the use of
SBOT for patients with COPD. The British National
Institute for Health and Clinical Excellence (NICE) has
recommended that short burst oxygen treatment should
“only be considered for episodes of severe breathlessness in
patients with COPD not relieved by other treatments....
and only if an improvement in breathlessness following
therapy has been documented.”[1] Our study provides
further support for this advice.
Conclusions
This study provides no support for the idea that COPD
patients who are not hypoxaemic at rest derive notice-
able benefit from oxygen therapy after exercise. This
negative result was in agreement with most previous
short-term trials of SOBT in patients with COPD. Use
of air from a mask or from a fan had no apparent phy-
siological or placebo effect. We would suggest that
SBOT should not be prescribed without a formal exer-
cise assessment such as that described in the present
study and it should be prescribed for home use only if a
patient with severe COPD has desaturated on exertion
with demonstrable improvement in breathlessness on
oxygen compared with air in a single-blind study and
the prescription should be continued only if there is
consistent use of the SBOT treatment over a period of
several months.
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